[go: up one dir, main page]

ES2196769T3 - Uso topico de loperamide para el tratamiento de infecciones microbianas. - Google Patents

Uso topico de loperamide para el tratamiento de infecciones microbianas.

Info

Publication number
ES2196769T3
ES2196769T3 ES99904829T ES99904829T ES2196769T3 ES 2196769 T3 ES2196769 T3 ES 2196769T3 ES 99904829 T ES99904829 T ES 99904829T ES 99904829 T ES99904829 T ES 99904829T ES 2196769 T3 ES2196769 T3 ES 2196769T3
Authority
ES
Spain
Prior art keywords
loperamide
treatment
microbial infections
topical use
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99904829T
Other languages
English (en)
Inventor
Carol Keene
Angus Malcolm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2196769T3 publication Critical patent/ES2196769T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

El uso de loperamida o de una sal farmacéuticamente aceptable de la misma para la fabricación de un medicamento tópico para usar en la prevención o el tratamiento de infecciones microbianas asociadas a los trastornos de la piel.
ES99904829T 1998-02-05 1999-01-29 Uso topico de loperamide para el tratamiento de infecciones microbianas. Expired - Lifetime ES2196769T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802542.2A GB9802542D0 (en) 1998-02-05 1998-02-05 New use

Publications (1)

Publication Number Publication Date
ES2196769T3 true ES2196769T3 (es) 2003-12-16

Family

ID=10826560

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99904829T Expired - Lifetime ES2196769T3 (es) 1998-02-05 1999-01-29 Uso topico de loperamide para el tratamiento de infecciones microbianas.

Country Status (9)

Country Link
US (1) US6566374B1 (es)
EP (1) EP1052991B1 (es)
AT (1) ATE236633T1 (es)
DE (1) DE69906701T2 (es)
DK (1) DK1052991T3 (es)
ES (1) ES2196769T3 (es)
GB (1) GB9802542D0 (es)
PT (1) PT1052991E (es)
WO (1) WO1999039711A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use
US7138459B2 (en) * 2004-04-02 2006-11-21 Adherent Laboratories, Inc. Water soluble contact lens blocking composition
US7220800B2 (en) * 2004-04-02 2007-05-22 Adherent Laboratories, Inc. Water soluble contact lens blocking composition with absorbent disintegrant
WO2007003941A1 (en) * 2005-07-06 2007-01-11 Cambridge Enterprise Limited Modulation of autophagy by calpain inhibition
US20080033021A1 (en) * 2006-08-02 2008-02-07 Susan Burke Wash composition for the handling of contact lenses
FR2969494B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906779A1 (de) * 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6156771A (en) * 1997-08-28 2000-12-05 Rubin; Walter Method for alleviation of lower gastrointestinal disorders in a human patient
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use

Also Published As

Publication number Publication date
GB9802542D0 (en) 1998-04-01
ATE236633T1 (de) 2003-04-15
EP1052991A1 (en) 2000-11-22
DK1052991T3 (da) 2003-08-04
WO1999039711A1 (en) 1999-08-12
DE69906701D1 (de) 2003-05-15
PT1052991E (pt) 2003-08-29
EP1052991B1 (en) 2003-04-09
US6566374B1 (en) 2003-05-20
DE69906701T2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
ES2526521T3 (es) Composiciones de antibiótico para el tratamiento del oído
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
AR028570A1 (es) Composiciones de polipcptidos tnxicas contra insectos anthonomus y mctodos para el uso de las mismas
FR11C0037I1 (es)
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
AR028041A1 (es) El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos
SE9904377D0 (sv) Pharmaceutical combinations
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
BR0004860B1 (pt) dispositivo para o condicionamento e a distribuição de uma composição e uso do dispositivo.
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
BR0115983A (pt) Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
MX9405371A (es) Derivado de naftilo.
CL2004001010A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
CL2004001007A1 (es) Compuestos derivados de macrolitos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
CL2004001009A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
CL2004001006A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceuticas que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topic